Home
ALVO

ALVO

Alvotech

as of 11-28-2025 12:34pm EST

$5.11

$0.04

-0.87%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Chart Type:

Time Range:

Founded:	2013	Country:	Luxembourg
Employees:	N/A	City:	N/A
Market Cap:	1.6B	IPO Year:	N/A
Target Price:	$10.67	AVG Volume (30 days):	820.8K
Analyst Decision:	Buy	Number of Analysts:	3
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	0.24	EPS Growth:	N/A
52 Week Low/High:	$4.70 - $13.70	Next Earning Date:	11-12-2025
Revenue:	$573,350,000	Revenue Growth:	45.55%
Revenue Growth (this year):	34.94%	Revenue Growth (next year):	39.55%

AI-Powered ALVO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 77.55%

77.55%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full ALVO Forecast & Prediction with Hourly Data

Compare ALVO vs Leading Stocks

See how ALVO stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free ALVO Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "ALVO Alvotech - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.